FindTrial
Sign In

Effect of the subcutaneous low molecular weight heparin injection technique on bruising and pain

Effect of the subcutaneous low molecular weight heparin injection technique on bruising and pain

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160426004
Enrollment
44
Registered
2016-04-26
Start date
2014-08-28
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DVT Deep Venous Thrombosis

Interventions

Patients were injected Enoxaparin 10 seconds then withdrawn. ,Patients were injected Enoxaparin30 seconds then waiting 10 seconds before needle withdrawn.
Active Comparator Procedure/Surgery,Experimental Procedure/Surgery
10 sec technic,30/10 sec technic

Sponsors

Siriraj Resarch Development Fund
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: age 18- 80 y Outpatient who receive Enoxaparin 1 mg/kg twice daily

Exclusion criteria

Exclusion criteria: &#45;Patients who have mental disorder that affects the brain and perception. &#45;receiving the drug. anticoagulant and antiplatelet addition &#45;Creatinine clearance < 30 ml/mi&#44;Platelet ≤ 100&#44;000 /ul&#44;APTT ≤ 23 or ≥ 32 sec&#44; PT ≤ 11 or ≥ 14 sec &#45;pregnancy or breastfeeding &#45;cann&#39;t follow up

Design outcomes

Primary

MeasureTime frame
briuse rate 48 hrs.and 60 hrs after patient&#39;s injection percent—

Secondary

MeasureTime frame
briuse area and pain level 48 hrs.and 60 hrs after patient&#39;s injection area measurement and NRS—

Countries

Thailand

Contacts

Public Contactsommapun jueakaew

siriraj hospital

sommapun.si@gmail.com66124198984

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026